These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26846404)

  • 1. Association of Biofilm Formation, Psl Exopolysaccharide Expression, and Clinical Outcomes in Pseudomonas aeruginosa Keratitis: Analysis of Isolates in the Steroids for Corneal Ulcers Trial.
    Zegans ME; DiGiandomenico A; Ray K; Naimie A; Keller AE; Stover CK; Lalitha P; Srinivasan M; Acharya NR; Lietman TM
    JAMA Ophthalmol; 2016 Apr; 134(4):383-9. PubMed ID: 26846404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of virulence factors, antimicrobial resistance patterns and biofilm formation of Pseudomonas aeruginosa and Staphylococcus spp. strains isolated from corneal infection.
    Heidari H; Hadadi M; Sedigh Ebrahim-Saraie H; Mirzaei A; Taji A; Hosseini SR; Motamedifar M
    J Fr Ophtalmol; 2018 Nov; 41(9):823-829. PubMed ID: 30292385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.
    Sy A; Srinivasan M; Mascarenhas J; Lalitha P; Rajaraman R; Ravindran M; Oldenburg CE; Ray KJ; Glidden D; Zegans ME; McLeod SD; Lietman TM; Acharya NR
    Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):267-72. PubMed ID: 22159005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis.
    Borkar DS; Fleiszig SM; Leong C; Lalitha P; Srinivasan M; Ghanekar AA; Tam C; Li WY; Zegans ME; McLeod SD; Lietman TM; Acharya NR
    JAMA Ophthalmol; 2013 Feb; 131(2):147-53. PubMed ID: 23411878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic clinical isolates of Pseudomonas aeruginosa identified during the Steroids for Corneal Ulcers Trial show elevated resistance to fluoroquinolones.
    Borkar DS; Acharya NR; Leong C; Lalitha P; Srinivasan M; Oldenburg CE; Cevallos V; Lietman TM; Evans DJ; Fleiszig SM
    BMC Ophthalmol; 2014 Apr; 14():54. PubMed ID: 24761794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Versatile Pseudomonas aeruginosa Biofilm Matrix Protein CdrA Promotes Aggregation through Different Extracellular Exopolysaccharide Interactions.
    Reichhardt C; Jacobs HM; Matwichuk M; Wong C; Wozniak DJ; Parsek MR
    J Bacteriol; 2020 Sep; 202(19):. PubMed ID: 32661078
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.
    Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Devi L; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    JAMA Ophthalmol; 2017 Jun; 135(6):520-525. PubMed ID: 28426856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psl Produced by Mucoid
    Jones CJ; Wozniak DJ
    mBio; 2017 Jun; 8(3):. PubMed ID: 28634241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India.
    Oldenburg CE; Lalitha P; Srinivasan M; Rajaraman R; Ravindran M; Mascarenhas J; Borkar DS; Ray KJ; Zegans ME; McLeod SD; Porco TC; Lietman TM; Acharya NR
    Ophthalmic Epidemiol; 2013 Jun; 20(3):155-8. PubMed ID: 23662986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of etiologic agents of bacterial keratitis from presentation characteristics.
    Mascarenhas J; Srinivasan M; Chen M; Rajaraman R; Ravindran M; Lalitha P; Oldenburg CE; Ray KJ; Glidden DV; Costanza S; Lietman TM; Acharya NR
    Int Ophthalmol; 2012 Dec; 32(6):531-8. PubMed ID: 22752605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual outcomes in treated bacterial keratitis: four years of prospective follow-up.
    McClintic SM; Prajna NV; Srinivasan M; Mascarenhas J; Lalitha P; Rajaraman R; Oldenburg CE; O'Brien KS; Ray KJ; Acharya NR; Lietman TM; Keenan JD
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2935-40. PubMed ID: 24618327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Psl Targeting of Pseudomonas aeruginosa Biofilms for Neutrophil-Mediated Disruption.
    Ray VA; Hill PJ; Stover CK; Roy S; Sen CK; Yu L; Wozniak DJ; DiGiandomenico A
    Sci Rep; 2017 Nov; 7(1):16065. PubMed ID: 29167572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of
    Long MB; Gilmour A; Kehl M; Tabor DE; Keller AE; Warrener P; Gopalakrishnan V; Rosengren S; Crichton ML; McIntosh E; Giam YH; Keir HR; Brailsford W; Hughes R; Belvisi MG; Sellman BR; DiGiandomenico A; Chalmers JD
    Am J Respir Crit Care Med; 2024 Jul; 210(1):35-46. PubMed ID: 38754132
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
    Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
    Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).
    Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Lalitha P; Glidden DV; Ray KJ; Hong KC; Oldenburg CE; Lee SM; Zegans ME; McLeod SD; Lietman TM; Acharya NR;
    Arch Ophthalmol; 2012 Feb; 130(2):143-50. PubMed ID: 21987582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early addition of topical corticosteroids in the treatment of bacterial keratitis.
    Ray KJ; Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Glidden DV; Oldenburg CE; Sun CQ; Zegans ME; McLeod SD; Acharya NR; Lietman TM
    JAMA Ophthalmol; 2014 Jun; 132(6):737-41. PubMed ID: 24763755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Survival Strategy for Pseudomonas aeruginosa That Uses Exopolysaccharides To Sequester and Store Iron To Stimulate Psl-Dependent Biofilm Formation.
    Yu S; Wei Q; Zhao T; Guo Y; Ma LZ
    Appl Environ Microbiol; 2016 Nov; 82(21):6403-6413. PubMed ID: 27565622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exopolysaccharide-Repressing Small Molecules with Antibiofilm and Antivirulence Activity against Pseudomonas aeruginosa.
    van Tilburg Bernardes E; Charron-Mazenod L; Reading DJ; Reckseidler-Zenteno SL; Lewenza S
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmentally Endemic Pseudomonas aeruginosa Strains with Mutations in lasR Are Associated with Increased Disease Severity in Corneal Ulcers.
    Hammond JH; Hebert WP; Naimie A; Ray K; Van Gelder RD; DiGiandomenico A; Lalitha P; Srinivasan M; Acharya NR; Lietman T; Hogan DA; Zegans ME
    mSphere; 2016; 1(5):. PubMed ID: 27631025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa exopolysaccharide Psl promotes resistance to the biofilm inhibitor polysorbate 80.
    Zegans ME; Wozniak D; Griffin E; Toutain-Kidd CM; Hammond JH; Garfoot A; Lam JS
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4112-22. PubMed ID: 22585230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.